Managing Depakote-Induced Tremors: How Propranolol Can Help?
Valproate is commonly prescribed in psychiatric and neurological settings for mood stabilization and seizure management. However, one potential side effect that can affect patients’ quality of life is tremor, a rhythmic and involuntary shaking, usually most apparent in the hands. Valproate-induced tremor is often dose-dependent but can occur even at therapeutic levels, and it may significantly impact daily functioning, particularly in patients needing fine motor skills.
This video is part of our third CME course on “Comprehensive Approaches for Managing Adverse Events with Psychopharmacology”, offering 6.75 AMA PRA Category 1 Credits.
- If you’re a medical professional looking to enhance your knowledge with evidence-based, clinically relevant material, I encourage you to enroll in the course. It’s designed to provide practical insights for improving patient outcomes in everyday clinical practice.
MANAGING DEPAKOTE INDUCED TREMORS:
PROPRANOLOL
CME ACADEMY #3
MANAGING ADVERSE EVENTS WITH PSYCHOPHARMACOLOGY
TOTAL CREDITS: 6.75 AMA PRA CATEGORY 1 CREDITS
LEARNING OBJECTIVES:
- Identify and manage common adverse effects associated with antipsychotics, Mood Stabilizers and Antidepressants.
- Develop targeted treatment plans for specific adverse events of antipsychotics like Clozapine and Mood Stabilizers like Lithium.
- Evaluate the comparative efficacy of VMAT-2 inhibitors for tardive dyskinesia management to optimize patient outcomes.
- Assess the relationship between antipsychotic use and breast cancer risk to guide safer long-term treatment planning.
- Recognize and address antidepressant-induced adverse effects, such as bruxism, excessive sweating, and other condition-specific risks, to improve patient comfort and adherence to treatment.
JOIN NOW
© 2025 All Rights Reserved.
